Stockreport

Leads Biolabs And Dianthus Therapeutics Announce Initiation of Phase 1 Trial Of LBL-047 (DNTH212) In Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) [Yahoo! Finance...

Dianthus Therapeutics, Inc.  (DNTH) 
PDF Top-line results in healthy volunteers anticipated in 2H'26 Dianthus to provide update on indication prioritization in 1H'26 LBL-047 (DNTH212) has the potential to [Read more]